|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 174.10 DKK | +0.17% |
|
-5.92% | -8.05% |
| Jun. 18 | Bavarian Nordic to Sell US Priority Review Voucher for $160 Million | MT |
| Jun. 18 | Bavarian Nordic is selling the PRV for $160 million. | FW |
Business description: Bavarian Nordic A/S
Net sales by revenue source are divided between sales of products (96.1%) and services (3.9%).
Net sales are distributed geographically as follows: the United States (47.3%), Germany (17%), Canada (8.6%), France (4.7%), Saudi Arabia (4.6%), Belgium (3.8%), Singapore (2.2%), and other (11.8%).
Number of employees: 1,645
Sales by Activity: Bavarian Nordic A/S
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
Biotechnology | 1.85B | 1.9B | 3.15B | 7.06B | 5.72B |
Geographical breakdown of sales: Bavarian Nordic A/S
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
USA | 1.14B | 1.07B | 842M | 2.58B | 2.7B |
Germany | 357M | 258M | 650M | 714M | 973M |
Canada | - | - | 197M | 1.56B | 493M |
Other Geographic Markets | 102M | 103M | 304M | 345M | 359M |
France | - | - | 268M | 740M | 269M |
Saudi Arabia | - | - | 100M | 4.84M | 266M |
Belgium | - | 264M | 335M | - | 218M |
Singapore | - | - | - | - | 125M |
Finland | - | - | - | - | 98.47M |
Netherlands | - | - | - | - | 69.79M |
Switzerland | 36.14M | 24.14M | 70.99M | 108M | 52.59M |
Sweden | 47.24M | 33.48M | - | 71.97M | 49.8M |
Taiwan | - | - | - | 53.8M | 40.05M |
Chile | - | - | - | 65.19M | - |
Spain | - | - | - | 430M | - |
Australia | - | - | 97.66M | 338M | - |
Hong Kong | - | - | 116M | 13.94M | - |
Japan | 21.06M | 24.11M | - | - | - |
United Kingdom | 23.07M | 16.98M | 169M | 44.72M | - |
Austria | 31.24M | 28.04M | - | - | - |
The Netherlands | 96.03M | 78.17M | - | - | - |
Executive Committee: Bavarian Nordic A/S
| Manager | Title | Age | Since |
|---|---|---|---|
Paul Chaplin
CEO | Chief Executive Officer | 58 | 2014-05-27 |
Henrik Juuel
DFI | Director of Finance/CFO | 60 | 2018-10-31 |
Russell Thirsk
COO | Chief Operating Officer | 57 | 2022-03-31 |
| Investor Relations Contact | - | - | |
Anu Helena Kerns
HRO | Human Resources Officer | 53 | 2020-10-31 |
Composition of the Board of Directors: Bavarian Nordic A/S
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 74 | 2010-04-26 | |
Frank Verwiel
BRD | Director/Board Member | 62 | 2016-04-19 |
Anne Eberhard
BRD | Director/Board Member | 62 | 2019-04-23 |
Thomas Bennekov
BRD | Director/Board Member | 57 | 2020-12-31 |
Anja Gjøl
BRD | Director/Board Member | 45 | 2020-12-31 |
Luc Debruyne
CHM | Chairman | 62 | 2023-02-28 |
Heidi Hunter
BRD | Director/Board Member | 66 | 2022-12-31 |
| Director/Board Member | 58 | 2022-12-31 | |
Montse Montaner
BRD | Director/Board Member | 57 | 2024-04-15 |
Holdings: Bavarian Nordic A/S
| Name | Equities | % | Valuation |
|---|---|---|---|
BAVARIAN NORDIC A/S 1.32% | 1,044,510 | 1.32% | 27,380,064 $ |
Company details: Bavarian Nordic A/S
Other Pharmaceuticals
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.17% | -5.92% | +12.00% | -18.30% | 2.08B | ||
| -2.84% | -6.07% | -14.44% | +162.20% | 705B | ||
| -0.62% | -4.39% | +2.84% | -11.61% | 363B | ||
| -2.58% | -8.36% | -51.66% | +27.37% | 333B | ||
| -0.10% | -3.70% | +8.13% | +34.00% | 328B | ||
| -0.27% | -4.88% | +3.80% | -14.52% | 255B | ||
| -0.34% | -3.24% | +1.03% | +20.14% | 228B | ||
| -1.52% | -5.78% | -15.79% | +4.72% | 220B | ||
| -0.29% | -3.37% | -38.23% | -6.57% | 199B | ||
| -0.10% | -2.68% | -5.44% | +23.27% | 156B | ||
| Average | -0.31% | -3.49% | -9.77% | +22.07% | 278.71B | |
| Weighted average by Cap. | -0.33% | -3.34% | -12.34% | +48.28% |
Sector
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- BAVA Stock
- Company Bavarian Nordic A/S
Select your edition
All financial news and data tailored to specific country editions
